Differential Mechanisms Associated with Vascular Disrupting Action of Electrochemotherapy: Intravital Microscopy on the Level of Single Normal and Tumor Blood Vessels

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Markelc, Bostjan ^a   Sersa, Gregor ^a   Cemazar, Maja ^a,b  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY OF PRIMORSKA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD VESSEL PARAMETERS; CANCER GROWTH; CELL STRAIN HT29; COLON ADENOCARCINOMA; CONTROLLED STUDY; DECREASED FUNCTIONAL VASCULAR DENSITY; DRUG EFFECT; DRUG MECHANISM; ELECTROCHEMOTHERAPY; ELECTROPORATION; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCREASED THE DIAMETER OF FUNCTIONAL BLOOD VESSEL; INTRAVITAL MICROSCOPY; MICROSCOPY; MOUSE; NONHUMAN; SCID MOUSE; TUMOR VASCULARIZATION; VASCULAR LOCK;

ANIMALS; BLEOMYCIN; BLOOD VESSELS; COLORECTAL NEOPLASMS; DEXTRANS; ELECTROCHEMOTHERAPY; ELECTROPORATION; FEMALE; HT29 CELLS; HUMANS; ISOTHIOCYANATES; MICE; MICROSCOPY;

MUS;

EID: 84875463023     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059557     Document Type: Article

References (54)

1. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, et al. (2008) Electrochemotherapy in treatment of tumours. Eur J Surg Oncol 34: 232-240.
2. Teissie J, Escoffre JM, Paganin A, Chabot S, Bellard E, et al. (2012) Drug delivery by electropulsation: Recent developments in oncology. Int J Pharm 423: 3-6.
3. Mir LM, Banoun H, Paoletti C, (1988) Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: Direct access to the cytosol. Exp Cell Res 175: 15-25.
4. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH, (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1: 841-845.
5. Chiarella P, Fazio VM, Signori E, (2010) Application of electroporation in DNA vaccination protocols. Curr Gene Ther 10: 281-286.
6. Sardesai NY, Weiner DB, (2011) Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol 23: 421-429.
7. Cemazar M, Jarm T, Sersa G, (2010) Cancer electrogene therapy with interleukin-12. Curr Gene Ther 10: 300-311.
8. Heller LC, Heller R, (2010) Electroporation gene therapy preclinical and clinical trials for melanoma. Curr Gene Ther 10: 312-317.
9. Cemazar M, Golzio M, Sersa G, Rols MP, Teissie J, (2006) Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand? Curr Pharm Des 12: 3817-3825.
10. Mir LM, (2009) Nucleic acids electrotransfer-based gene therapy (electrogenetherapy): past, current, and future. Mol Biotechnol 43: 167-176.
11. Sedlar A, Dolinsek T, Markelc B, Prosen L, Kranjc S, et al. (2012) Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol 46: 302-311.
12. Sersa G, Beravs K, Cemazar M, Miklavcic D, Demsar F, (1998) Contrast Enhanced MRI Assessment of Tumor Blood Volume After Application of Electric Pulses. Electromagn Biol Med 17: 299-306.
13. Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, et al. (2008) Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 98: 388-398.
14. Bellard E, Markelc B, Pelofy S, Le Guerroue F, Sersa G, et al. (2012) Intravital microscopy at the single vessel level brings new insights of vascular modification mechanisms induced by electropermeabilization. J Control Release 163: 396-403.
15. Gehl J, Skovsgaard T, Mir LM, (2002) Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta 1569: 51-58.
16. Markelc B, Bellard E, Sersa G, Pelofy S, Teissie J, et al. (2012) In vivo molecular imaging and histological analysis of changes induced by electric pulses used for plasmid DNA electrotransfer to the skin: a study in a dorsal window chamber in mice. J Membr Biol 245: 545-554.
17. Ramirez LH, Orlowski S, An D, Bindoula G, Dzodic R, et al. (1998) Electrochemotherapy on liver tumours in rabbits. Br J Cancer 77: 2104-2111.
18. Sersa G, Cemazar M, Miklavcic D, Chaplin DJ, (1999) Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res 19: 4017-4022.
19. Sersa G, Cemazar M, Parkins CS, Chaplin DJ, (1999) Tumour blood flow changes induced by application of electric pulses. Eur J Cancer 35: 672-677.
20. Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, et al. (2001) Reduced tumor oxygenation by treatment with vinblastine. Cancer Res 61: 4266-4271.
21. Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, et al. (2002) Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. Br J Cancer 87: 1047-1054.
22. Jarm T, Cemazar M, Miklavcic D, Sersa G, (2010) Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 10: 729-746.
23. Gehl J, Geertsen PF, (2000) Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 10: 585-589.
24. Snoj M, Cemazar M, Srnovrsnik T, Kosir SP, Sersa G, (2009) Limb sparing treatment of bleeding melanoma recurrence by electrochemotherapy. Tumori 95: 398-402.
25. Maor E, Ivorra A, Leor J, Rubinsky B, (2007) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6: 307-312.
26. Onik G, Mikus P, Rubinsky B, (2007) Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 6: 295-300.
27. Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, et al. (2007) Tumor ablation with irreversible electroporation. PLoS One 2: e1135.
28. Agerholm-Larsen B, Iversen HK, Ibsen P, Moller JM, Mahmood F, et al. (2011) Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res 71: 3753-3762.
29. Edhemovic I, Gadzijev EM, Brecelj E, Miklavcic D, Kos B, et al. (2011) Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat 10: 475-485.
30. Linnert M, Iversen HK, Gehl J, (2012) Multiple brain metastases- current management and perspectives for treatment with electrochemotherapy. Radiol Oncol 46: 271-278.
31. Dreher MR, Liu W, Michelich CR, Dewhirst MW, Yuan F, et al. (2006) Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst 98: 335-344.
32. Jain RK, Munn LL, Fukumura D, (2002) Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer 2: 266-276.
33. Palmer GM, Fontanella AN, Shan S, Hanna G, Zhang G, et al. (2011) In vivo optical molecular imaging and analysis in mice using dorsal window chamber models applied to hypoxia, vasculature and fluorescent reporters. Nat Protoc 6: 1355-1366.
34. Alexander S, Koehl GE, Hirschberg M, Geissler EK, Friedl P, (2008) Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model. Histochem Cell Biol 130: 1147-1154.
35. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, et al. (2006) Electrochemotherapy- An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 4: 3-13.
36. Frost GI, Borgstrom P (2003) Real time in vivo quantitation of tumor angiogenesis. In: Buolamwini JK, Adjei AA, editors. Novel AntiCancer Drug Protocols. Totowa, New Yersey, USA: Humana Press. 65-78.
37. Sersa G, Cemazar M, Miklavcic D, Mir LM (1994) Electrochemotherapy: variable anti-tumor effect on different tumor models. Bioelectrochem Bioenerg: 23-27.
38. Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, et al. (2000) Toxicity of anticancer agents mediated by electroporation in vitro. Anti-Cancer Drugs 11: 201-208.
39. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C, (1991) Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 27: 68-72.
40. Frandsen SK, Gissel H, Hojman P, Tramm T, Eriksen J, et al. (2012) Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res 72: 1336-1341.
41. Miklavcic D, Towhidi L, (2010) Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells. Radiol Oncol 44: 34-41.
42. Sentjurc M, Cemazar M, Sersa G, (2004) EPR oximetry of tumors in vivo in cancer therapy. Spectrochimica acta Part A, Molecular and biomolecular spectroscopy 60: 1379-1385.
43. Tozer GM, Kanthou C, Baguley BC, (2005) Disrupting tumour blood vessels. Nat Rev Cancer 5: 423-435.
44. Kanthou C, Kranjc S, Sersa G, Tozer G, Zupanic A, et al. (2006) The endothelial cytoskeleton as a target of electroporation-based therapies. Mol Cancer Ther 5: 3145-3152.
45. Cemazar M, Parkins CS, Holder AL, Chaplin DJ, Tozer GM, et al. (2001) Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. Br J Cancer 84: 565-570.
46. Matthiessen LW, Johannesen HH, Hendel HW, Moss T, Kamby C, et al. (2012) Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol 51: 713-721.
47. Folkman J, (2003) Angiogenesis and apoptosis. Semin Cancer Biol 13: 159-167.
48. Ching LM, Zwain S, Baguley BC, (2004) Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice. Br J Cancer 90: 906-910.
49. Patel RB, Kotha SR, Sauers LA, Malireddy S, Gurney TO, et al. (2012) Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N'-bis-2-mercaptoethyl isophthalamide. Toxicol Mech Methods 22: 383-396.
50. Siemann DW, (2011) The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents. Cancer Treat Rev 37: 63-74.
51. Meulenberg CJ, Todorovic V, Cemazar M, (2012) Differential cellular effects of electroporation and electrochemotherapy in monolayers of human microvascular endothelial cells. PLoS One 7: e52713.
52. Ellis TL, Garcia PA, Rossmeisl JH Jr, Henao-Guerrero N, Robertson J, et al. (2011) Nonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation. J Neurosurg 114: 681-688.
53. Maor E, Ivorra A, Rubinsky B, (2009) Non thermal irreversible electroporation: novel technology for vascular smooth muscle cells ablation. PLoS One 4: e4757.
54. Ivorra A, Rubinsky B, (2007) In vivo electrical impedance measurements during and after electroporation of rat liver. Bioelectrochemistry 70: 287-295.